18:30 -19:00 Registration
19:00-19:05 Opening ceremony Speaker: ROVI representative
19:05-19:15 Welcome reception Speakers: Dr. Juan I. Arcelus and Dr. Juan V. Llau
19:15-20:00 Evolution in the impact of VTE Speaker: Dr. Juan I. Arcelus
20:00-22:00 Welcome dinner
9:00-10:00 Registration
10:00-10:15 Welcome Speaker: Dr. Juan I. Arcelus and Dr. Juan V. Llau
10:15-10:40 Factors influencing cancer-associated thrombosis Speaker: Dr. Ingrid Pabinger
10:40-10:50 Q&A
10:50-11:15 Perinatal thrombosis: identifying high-risk patients and preventative measures Speaker: Dr. Ingrid Bistervels
11:15-11:25 Q&A
11:25-11:55 Coffee Break
11:55-12:25 Pros & Cons: Is it necessary to monitor anti-Xa levels in specific populations receiving LMWHs? Speakers: Drs. Ingrid Pabinger & Ingrid Bistervels
12:25-12:35 Q&A
12:35-13:05 Pros & Cons: DVT and PE, does one treatment fit both? Speakers: Drs. Cecilia Becattini & Nikolaos Tsoukalas
13:05-13:15 Q&A
13:15-14:45 Lunch Break
14:45-15:15 Pros & Cons: Surgical thromboprophylaxis: LMWHs or DOACs? Speakers: Drs. Juan I. Arcelus & Juan V. Llau
15:15-15:25 Q&A
15:25-15:55 VTE in patients with autoimmune diseases Speaker: Dr. Karen Schreiber
15:55-16:05 Q&A
16:05-17:05 Clinical cases workshops Speakers: Drs. Cecilia Becattini & Nikolaos Tsoukalas
17:05-17:15 Concluding remarks. Speakers: Dr. Juan I. Arcelus and Dr. Juan V. Llau
